Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients

被引:0
|
作者
Andrea Dalbeni
Alessandro Giollo
Michele Bevilacqua
Giovanni Cioffi
Angela Tagetti
Filippo Cattazzo
Giovanni Orsolini
Federica Ognibeni
Pietro Minuz
Maurizio Rossini
Cristiano Fava
Ombretta Viapiana
机构
[1] University and Azienda Ospedaliera Universitaria Integrata of Verona,Division of General Medicine and Hypertension, Department of Medicine
[2] University and Azienda Ospedaliera Universitaria Integrata of Verona,Division of Rheumatology, Department of Medicine
来源
Hypertension Research | 2020年 / 43卷
关键词
Traditional cardiovascular risk factors; Subclinical atherosclerosis; Rheumatoid arthritis; Residual disease activity;
D O I
暂无
中图分类号
学科分类号
摘要
Patients with rheumatoid arthritis (RA) have an increased incidence of cardiovascular events. Ultrasound examination of the carotid arteries can show the presence of plaques and detect the atherosclerotic subclinical process through the evaluation of intima-media thickness (cIMT) and carotid segmental distensibility (cCD). The aim of the present study was to identify which factors could independently influence the evolution of atherosclerosis (plaques, cIMT, and cCD) after 1 year of follow-up in a sample of patients with RA. A total of 137 patients with RA without previous cardiovascular (CV) events were enrolled at baseline, and 105 (M/F: 21/84, age 59.34 ± 11.65 years) were reassessed after one year using ultrasound of carotid arteries to detect atheromatous plaques and to measure cIMT and cCD. After one year, all the indices of subclinical atherosclerosis worsened with respect to baseline (Δ-cIMT = 0.030 ± 0.10 mm, p = 0.005; Δ-cCD = −1.64 ± 4.83, 10–3/KPa, p = 0.005; Δ-plaques = 8.6%, p = 0.035). Traditional CV risk factors (age, mean arterial pressure, and diabetes) and corticosteroid therapy were independently associated with the worsening of subclinical atherosclerosis. Interestingly, when considering RA patients divided according to the degree of disease activity score 28 with C-reactive protein (DAS28 [CRP] ≥2.6), the worsening of subclinical atherosclerosis indices was detectable exclusively in the group of patients with active disease. Our longitudinal study supports the hypothesis of a key role of both traditional CV risk factors and the inflammatory activity of arthritic disease in the progression of subclinical atherosclerosis in RA patients. In addition, corticosteroids might have a deleterious effect.
引用
收藏
页码:922 / 928
页数:6
相关论文
共 50 条
  • [21] The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study
    G. V. Papamichail
    T. E. Markatseli
    A. N. Georgiadis
    V. G. Xydis
    H. Milionis
    A. A. Drosos
    P. V. Voulgari
    Heart and Vessels, 2022, 37 : 2128 - 2136
  • [22] The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study
    Papamichail, G., V
    Markatseli, T. E.
    Georgiadis, A. N.
    Xydis, V. G.
    Milionis, H.
    Drosos, A. A.
    Voulgari, P. V.
    HEART AND VESSELS, 2022, 37 (12) : 2128 - 2136
  • [23] Cardiovascular Events Are Not Associated with MTHFR Polymorphisms, But Are Associated with Methotrexate Use and Traditional Risk Factors in US Veterans with Rheumatoid Arthritis
    Davis, Lisa A.
    Cannon, Grant W.
    Pointer, Lauren F.
    Haverhals, Leah M.
    Wolff, Roger K.
    Mikuls, Ted R.
    Reimold, Andreas M.
    Kerr, Gail S.
    Richards, J. Steuart
    Johnson, Dannette S.
    Valuck, Robert
    Prochazka, Allan
    Caplan, Liron
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 809 - 817
  • [24] The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritis
    Karpouzas, George A.
    Ormseth, Sarah R.
    Hernandez, Elizabeth
    Budoff, Matthew J.
    RHEUMATOLOGY, 2022, 61 (05) : 1857 - 1866
  • [25] Application of cardiovascular risk scales to identify carotid atherosclerosis in patients with rheumatoid arthritis
    Gerasimova, Elena, V
    Popkova, Tatiana, V
    Gerasimova, Daria A.
    Glukhova, Svetlana, I
    Nasonov, Evgeny L.
    Lila, Aleksander M.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (05) : 561 - 567
  • [26] Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis
    Patrick H Dessein
    Barry I Joffe
    Sham Singh
    Arthritis Research & Therapy, 7
  • [27] The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients
    Arts, Elke E. A.
    Fransen, Jaap
    den Broeder, Alfons A.
    Popa, Calin D.
    van Riel, Piet L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 998 - 1003
  • [28] Novel risk factors for cardiovascular disease in rheumatoid arthritis
    Jenny Amaya-Amaya
    Juan Camilo Sarmiento-Monroy
    Ruben-Dario Mantilla
    Ricardo Pineda-Tamayo
    Adriana Rojas-Villarraga
    Juan-Manuel Anaya
    Immunologic Research, 2013, 56 : 267 - 286
  • [29] Novel risk factors for cardiovascular disease in rheumatoid arthritis
    Amaya-Amaya, Jenny
    Camilo Sarmiento-Monroy, Juan
    Mantilla, Ruben-Dario
    Pineda-Tamayo, Ricardo
    Rojas-Villarraga, Adriana
    Anaya, Juan-Manuel
    IMMUNOLOGIC RESEARCH, 2013, 56 (2-3) : 267 - 286
  • [30] Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Han, Chenglong
    Robinson, Don W.
    Hackett, Monica V.
    Paramore, L. Clark
    Fraeman, Kathy H.
    Bala, Mohan V.
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (11) : 2167 - 2172